, and nucleic acid aptamers. At present, we are using neurochips to identify rare nucleotides isolated from combinatorial libraries consisting of hundreds of billions of candidate sequences based on relative affinities for small-molecule neurotransmitter targets. We have also developed micro-to nanoscale surface patterning techniques (Liao et al, 2012) and used high-throughput microfluidics (Liao et al, 2013) to create multiplexed neurotransmitter substrates. A significant advantage of multiplexed patterning is the capacity to capture and to sort different neurotransmitterspecific aptamers side-by-side while providing opportunities to determine and to compare in situ binding affinities.
The discovery of neurotransmitter aptamers will enable their functional integration into nanometer-diameter field-effect transistor (FET) nanowires, which will function as neurotransmitter recording elements (Figure 1 ). Devices patterned with aptamer-modified FETs will be used to carry out dynamic in vivo monitoring of neurotransmission with response times on the order of milliseconds (or faster) (Kim et al, 2015) . When combined with appropriate passivation to suppress biofouling, microsensors that detect dopamine with sub-second temporal resolution have been shown to function over months in vivo in rats and mice (Clark et al, 2010) . Thus, neurochips will enable the development of devices that will advance the understanding of the roles of small-molecule neurotransmitters in the complex landscape of brain interneuronal communication and dysfunction. Unraveling the emergent properties of integrated chemical neurotransmission associated with neural circuits using this approach will be advantageous for uncovering processes associated with cognition, emotion, and learning and memory.
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Second, neural plasticity can help. A recent surprise from BCI studies is that models are helpful, but not always necessary. A motivated subject can learn to skillfully control a prosthetic limb or an internal neurostimulator, even if the mapping between neural firing and device behavior does not match 'natural' input-output relationships. As the user trains with the BCI, the brain re-maps its firing patterns to match the device's control scheme (Moritz and Fetz, 2011) . In effect, the decoded patterns become a readout of the user's intention-what he/she wants the device to do at that moment. For a prosthetic limb, this is an instantaneous motion command. For psychiatry, it would be a stimulator command. For instance, one could place a recording electrode in an area that contains emotion-related signals, then link the amplitude of a DBS intervention to the intention-modulated signals in that area. The patient's signals in the recorded area would then 'tune' the DBS intervention as needed. We recently showed that rodents can learn to use prefrontal cortex signals in precisely this fashion to activate DBS-like stimulation (Widge and Moritz, 2014) . Similar strategies may be useful for modulating fear behaviors in anxiety disorders, using fronto-limbic networks as targets (Besnard and Sahay, 2015) .
DBS remains an interesting technique, and closed-loop approaches may make it more useful for a broader group of patients. Despite recent clinical trial failures, the prospects for psychiatric DBS may be brighter than ever.
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